Although he only left him a 10% stake, the benefits represented by this percentage are also extremely staggering compared to the astronomical wealth that the new anti-cancer drugs will create in the future.

If you change to someone else, you either don't agree, the drug is stuck by the Food and Drug Administration, and you can't pass the review for a long time, and billions of R&D funds are wasted, and you can't get back a penny of cost, or you will give up most of the benefits, and keep that one percent of the shares is enough for him to make a lot of money, I believe that the vast majority of people will choose to give in in the face of this situation!

However, this naturally does not include Chen Mo, let alone ninety percent, Chen Mo will not even give up one percent of the shares!

Play this trick with me, you've found the wrong person!

Chen Moquan clearly heard the content of the other party's phone call just now, although the president of Merck Pharmaceutical Group did not say a word of threat, but combined with the fact that their drug review had just been stuck by the Food and Drug Administration, this phone call was actually a threat!

Either cooperate and give up most of the benefits, or you will be completely stuck, and you won't get a penny back!

The fact that the other party can make the Food and Drug Administration change its face and block them is enough to show that they have a strong strength, and they naturally have the confidence to deal with the counterattack of the Aegis creatures.

The Food and Drug Administration did not violate any regulations, but just acted according to the rules, at most it can be said that they were a little rigid, and the starting point was still for drug safety!

Even if it makes a fuss in the media, it will not affect them, and they still need to conduct long-term clinical trials according to the regulations, and then wait for further review.

At that time, they can continue to delay for various reasons, as long as Chen Mo does not compromise, the Aegis creatures will be completely stuck!

Chen Mo is almost certain that there is probably not just a pharmaceutical company behind Merck Pharmaceutical Group!

But will Chen Mo be threatened?

That's probably the only thing they're missing!

"Send people to contact the health departments of Huaxia, Europe and other countries, and say that we intend to open branches in their countries, establish pharmaceutical factories, and put this new anti-cancer drug on the market in their countries first!"

Chen Mo said calmly.

Su Wan's eyes couldn't help but light up when she heard this, why didn't she think of it!

Generally, the new drugs developed by pharmaceutical companies will first pass the review in their own country, and then enter other countries, and the process of re-review will be much simpler, and almost no one will go to other countries for the initial review of the drug.

However, this is a very good way for them, since the Food and Drug Administration of the United States has stuck their new anti-cancer drugs, they can go to other countries for review, even if the United States does not recognize the audit results of other countries, it is a big deal to give up the rice market, the world is so big, and it is not that the United States will not be able to live without the United States!

When their new anti-cancer drugs are first marketed in other countries and see the actual effect, I don't know if these officials of the Food and Drug Administration will be drowned by the saliva of the people of the United States!

As for the people of the United States who have no way to receive treatment, don't forget, Su Wan and Chen Moke are both Chinese!

If there are good things, they will naturally cling to their own compatriots first, and if the officials of your own country die, we can't help it!

The previous review in the United States was just for convenience, and when the review is passed, whether it is Su Wan or Chen Mo, they will not forget their Chinese compatriots, and they will inevitably put this drug on the Chinese market at the same time.

The current situation they need to re-review in various countries, although it may lead to the delay of the drug marketing, but Huaxia must still be their primary target, as for the rice country that could be the first batch of beneficiary countries with Huaxia, it is likely to become the last country in the world to launch new anti-cancer drugs!

Su Wandang, who suddenly opened up her heart, even began to contact the health departments of Huaxia and European countries, expressing her willingness to open branches and conduct drug audits in various countries.

When countries received the news, they were very surprised, yes, surprises!

The new anti-cancer drug of Aegis Bio has been reported by major media in the United States before, and has long been known by countries around the world, and the health departments of various countries attach great importance to this drug that may completely cure cancer, and they have also sent people to investigate the clinical trial of this new anti-cancer drug, and found that the media did not exaggerate, and Aegis Bio did not falsify.

Compared with the results of the analysis and examination of the condition of these cancer patients before and after, the effect of the drug is clear at a glance, and it does inhibit the proliferation and spread of cancer cells, and the condition of all the patients participating in the trial has been greatly improved, which is unimaginable for most of these patients with advanced cancer and may die at any time!

It's just that according to the normal situation, this drug will inevitably be the first to pass the review in the United States, and after obtaining the license, it will be put on the world market, and they just want to contact Aegis Technology to introduce this drug into their country as soon as possible after the drug has passed the review.

As for letting Aegis Biotech go to their country for drug review, there has never been such a precedent before.

This is like taking a driver's license, who will not drive to other places after taking a driver's license in their hometown or the location of a school or company, and who will go all the way to other places to get a driver's license.

But now Aegis creatures are doing just that!

Therefore, after receiving the request of Aegis Biotech to build a branch in their own country and conduct drug review, all countries were pleasantly surprised, because this also means that this new anti-cancer drug will be the first to be put into use in their country!

Moreover, Aegis Biotech not only sets up branches, but also builds factories in various countries, which means that this drug will be changed from imported to domestic, avoiding high import and export tariffs, and the final price will be much cheaper!

In addition to the tangible benefits to cancer patients in their country, this is also a huge achievement for them!

They had no reason to refuse, but they were all enthusiastic, and came up with various preferential policies, hoping that Aegis Biotech could take the lead in building a factory and putting it on the market in their country.

Some other countries that Su Wan did not contact, such as India, Japan, Australia and other countries, also took the initiative to contact Aegis Biotech and sent invitations one after another, hoping that Aegis Biotech could establish branches in their countries, and promised to simplify the drug review process.

However, in fact, this kind of audit does not need to be conducted in every country, as long as one country has issued a drug license, the review of other countries will be much easier.

。 vertex